Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Clin Cancer Res. 2016 May 25;22(19):4776–4785. doi: 10.1158/1078-0432.CCR-16-0506

Figure 2. Onset and sustainability of vaccine induced immune responses.

Figure 2

(A) Onset (first appearance) of vaccine-induced immune responses to IMA950 TUMAPs (n=77 total detected vaccine-induced responses in n=40 immune evaluable patients). (B) The percentage of vaccine-induced responses to IMA950 TUMAPs with detection at one, two or three post-vaccination assay time points. p-values were calculated using the Fisher’s exact test (only significant results are shown).

Abbreviations: TUMAP, tumor associated peptide; VI, vaccine induced.